
|Articles|February 15, 2004
On the market: An update on surgical business sale
Last summer, Pfizer Inc. announced it was selling the surgical ophthalmic business acquired in the acquisition of Pharmacia Inc. (See Ophthalmology Times, Sept. 1, 2003 issue, Page 3).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Avisi Technologies releases positive 12-month data from VITA Trial
3
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
4
Selecting Anti-VEGF Therapies in Retinal Vascular Disease Management
5


















































.png)


